Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 5
1989 12
1990 6
1991 8
1992 10
1993 10
1994 20
1995 23
1996 23
1997 27
1998 17
1999 22
2000 29
2001 31
2002 25
2003 31
2004 24
2005 19
2006 15
2007 11
2008 6
2009 15
2010 11
2011 19
2012 15
2013 10
2014 14
2015 8
2016 10
2017 14
2018 10
2019 3
2020 6
2021 5
2022 10
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

504 results

Results by year

Filters applied: . Clear all
Page 1
Lee DK, Currie GP, Lipworth BJ. Lee DK, et al. Among authors: lipworth bj. N Engl J Med. 2005 Mar 17;352(11):1155-7; author reply 1155-7. doi: 10.1056/NEJM200503173521124. N Engl J Med. 2005. PMID: 15784676 No abstract available.
Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS).
Cotton S, Devereux G, Abbas H, Briggs A, Campbell K, Chaudhuri R, Choudhury G, Dawson D, De Soyza A, Fielding S, Gompertz S, Haughney J, Lang CC, Lee AJ, MacLennan G, MacNee W, McCormack K, McMeekin N, Mills NL, Morice A, Norrie J, Petrie MC, Price D, Short P, Vestbo J, Walker P, Wedzicha J, Wilson A, Lipworth BJ. Cotton S, et al. Among authors: lipworth bj. Trials. 2022 Apr 14;23(1):307. doi: 10.1186/s13063-022-06226-8. Trials. 2022. PMID: 35422024 Free PMC article. Clinical Trial.
Bisoprolol in Patients With Chronic Obstructive Pulmonary Disease at High Risk of Exacerbation: The BICS Randomized Clinical Trial.
Devereux G, Cotton S, Nath M, McMeekin N, Campbell K, Chaudhuri R, Choudhury G, De Soyza A, Fielding S, Gompertz S, Haughney J, Lee AJ, MacLennan G, Morice A, Norrie J, Price D, Short P, Vestbo J, Walker P, Wedzicha J, Wilson A, Wu O, Lipworth BJ. Devereux G, et al. Among authors: lipworth bj. JAMA. 2024 May 19. doi: 10.1001/jama.2024.8771. Online ahead of print. JAMA. 2024. PMID: 38762800
Levalbuterol kinetics.
Lipworth BJ, Clearie K. Lipworth BJ, et al. J Allergy Clin Immunol. 2009 Jan;123(1):275. doi: 10.1016/j.jaci.2008.10.055. J Allergy Clin Immunol. 2009. PMID: 19130946 No abstract available.
Leukotriene-receptor antagonists.
Lipworth BJ. Lipworth BJ. Lancet. 1999 Jan 2;353(9146):57-62. doi: 10.1016/S0140-6736(98)09019-9. Lancet. 1999. PMID: 10023966 Review.
Un-diagnosing persistent adult asthma.
Lipworth BJ, Jabbal S. Lipworth BJ, et al. Eur Respir J. 2017 Nov 2;50(5):1701433. doi: 10.1183/13993003.01433-2017. Print 2017 Nov. Eur Respir J. 2017. PMID: 29097435 Free article. No abstract available.
Salmeterol and tolerance.
Lipworth BJ, Jackson CM. Lipworth BJ, et al. Chest. 2000 Feb;117(2):609-11. doi: 10.1378/chest.117.2.609. Chest. 2000. PMID: 10669718 No abstract available.
Optimizing bronchodilator therapy for copd.
Lipworth BJ. Lipworth BJ. Chest. 2001 Jun;119(6):1628-30. doi: 10.1378/chest.119.6.1628. Chest. 2001. PMID: 11399680 No abstract available.
504 results